| Indicators | Browse All

InterCure Ltd. (INCR)

Healthcare | Drug Manufacturers - Specialty & Generic | Herzliya, Israel | NasdaqGM
5.78 USD +0.10 (1.761%) ⇧ (Aug. 28, 2026, 4 p.m. EDT)
After hours: 5.78

Short-term:★★☆☆☆Long-term:★⯪☆☆☆Dividends:☆☆☆☆☆
Hot Take | Aug. 22, 2026, 5:17 a.m. EDT

The investment case here is fractured by a complete lack of profitability and a deteriorating operational reality. Despite reporting a 43.8% revenue surge, the company remains deeply unprofitable with negative free cash flow and a forward P/E that is mathematically undefined due to losses. The balance sheet shows a concerning debt-to-equity ratio of 46%, and the recent news of a 5-for-1 reverse share split suggests management is trying to engineer a price floor to attract retail attention, a classic hallmark of distressed micro-cap stocks. While the recent price action shows some resilience, trading near its 52-week low, the fundamental picture is one of a business burning cash without a clear path to sustainable earnings. The options market is pricing in a fantasy scenario of a multi-bagger recovery via a reverse split, but the underlying fundamentals do not currently support such a leap. This is a high-risk speculative vehicle, not a sound investment.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
AutoTheta ✓0.088886
AutoARIMA0.101275
MSTL0.103096
AutoETS0.106537

Forecast horizon: 45 days | Selected: AutoTheta

Forecast Reliability
Score 42%
H-stat 0.84
Ljung-Box p 0.000
Jarque-Bera p 0.933
Excess Kurtosis 0.21
Attribute Value
Sector Healthcare
Debt to Equity Ratio 46.174
Market Cap 86,721,776
Forward P/E -3.91
Beta 0.57
Profit Margins -13.22%
Website https://www.intercure.co

As of Aug. 22, 2026, 5:17 a.m. EDT: Options activity is dominated by out-of-the-money calls with significant open interest at strikes far above the current price (2.5 and 5.0), suggesting speculative bets on a massive rally or a reverse split event rather than immediate near-term upside. The absence of any put activity indicates a lack of hedging or bearish positioning, while implied volatility remains low, reflecting a market that sees limited probability of a near-term crash despite the deep out-of-the-money call skew.


Info Dump

Attribute Value
52 Week Change -0.3030675
Address1 85 Medinat ha-Yehudim Street
All Time High 49.95
All Time Low 1.5
Ask 1.03
Ask Size 11
Average Daily Volume10 Day 112,956
Average Daily Volume3 Month 26,301
Average Volume 26,301
Average Volume10Days 112,956
Beta 0.573
Bid 1.01
Bid Size 1
Book Value 7.591
City Herzliya
Compensation As Of Epoch Date 1,767,139,200
Country Israel
Crypto Tradeable 0
Currency USD
Current Price 5.78
Current Ratio 1.478
Custom Price Alert Confidence HIGH
Date Short Interest 1,786,665,600
Day High 5.89
Day Low 5.6948
Debt To Equity 46.174
Display Name InterCure
Earnings Timestamp End 1,756,731,600
Earnings Timestamp Start 1,756,386,000
Ebitda -55,343,000
Ebitda Margins -0.20482
Eps Forward -1.48
Eps Trailing Twelve Months -1.11
Esg Populated 0
Exchange NGM
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fax 972 9 768 0244
Fifty Day Average 4.9136
Fifty Day Average Change 0.86640024
Fifty Day Average Change Percent 0.17632698
Fifty Two Week Change Percent -30.306751
Fifty Two Week High 8.45
Fifty Two Week High Change -2.6699996
Fifty Two Week High Change Percent -0.3159763
Fifty Two Week Low 3.4
Fifty Two Week Low Change 2.38
Fifty Two Week Low Change Percent 0.7
Fifty Two Week Range 3.4 - 8.45
Financial Currency ILS
First Trade Date Milliseconds 1,548,685,800,000
Float Shares 7,608,689
Forward Eps -1.48
Forward P E -3.9054055
Free Cashflow -37,432,376
Full Exchange Name NasdaqGM
Full Time Employees 285
Fullday Change 0.1
Fullday Change Percent 1.76057
Fullday Price 5.78
Gmt Off Set Milliseconds -14,400,000
Gross Margins 0.15064
Has Pre Post Market Data 1
Held Percent Insiders 0.39173
Held Percent Institutions 0.01053
Implied Shares Outstanding 15,003,767
Industry Drug Manufacturers - Specialty & Generic
Industry Disp Drug Manufacturers - Specialty & Generic
Industry Key drug-manufacturers-specialty-generic
Ir Website http://www.resperate.com/investor-relations/
Is Earnings Date Estimate 1
Language en-US
Last Fiscal Year End 1,767,139,200
Last Split Date 1,787,529,600
Last Split Factor 1:5
Long Business Summary InterCure Ltd., together with its subsidiaries, engages in the production, manufacturing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.
Long Name InterCure Ltd.
Market us_market
Market Cap 86,721,776
Market State CLOSED
Max Age 86,400
Message Board Id finmb_36626000
Most Recent Quarter 1,767,139,200
Next Fiscal Year End 1,798,675,200
Non Diluted Market Cap 67,283,638
Open 5.7
Operating Margins 0.0
Payout Ratio 0.0
Phone 972 7 746 05012
Post Market Change 0.0
Post Market Change Percent 0.0
Post Market Price 5.78
Post Market Time 1,787,959,806
Previous Close 5.68
Price Hint 2
Price To Book 0.761428
Profit Margins -0.13216
Quick Ratio 0.91
Quote Source Name Nasdaq Real Time Price
Quote Type EQUITY
Recommendation Key none
Region US
Regular Market Change 0.1
Regular Market Change Percent 1.76057
Regular Market Day High 5.89
Regular Market Day Low 5.6948
Regular Market Day Range 5.6948 - 5.89
Regular Market Open 5.7
Regular Market Previous Close 5.68
Regular Market Price 5.78
Regular Market Time 1,787,947,201
Regular Market Volume 5,326
Return On Assets -0.05784
Return On Equity -0.092650004
Revenue Growth 0.239
Sand P52 Week Change 0.20504117
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Shares Outstanding 15,003,767
Shares Percent Shares Out 0.0002
Shares Short 2,241
Shares Short Previous Month Date 1,784,073,600
Shares Short Prior Month 2,176
Short Name Intercure Ltd.
Short Percent Of Float 0.0002
Short Ratio 0.79
Source Interval 15
Symbol INCR
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps -1.11
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 4.868975
Two Hundred Day Average Change 0.91102505
Two Hundred Day Average Change Percent 0.18710817
Type Disp Equity
Volume 5,326
Website https://www.intercure.co
Zip 4,676,670